Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Virology|October 1, 1995
Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutantsV Calvez, I Pelletier, T Couderc, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
Dermatology (Basel, Switzerland)|October 12, 2011
Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature reviewF Brunet-Possenti, N Franck, J Tamburini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 30, 2017
Syphilis surveillance in France, 2000-2003E Couturier, A Michel, M Janier, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1994
[Pachydermodactyly]N Dupin, M S Gautier, G Rabary, et al.
The British Journal of Dermatology|August 6, 2013
Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomasE Regnier-Rosencher, H Lazareth, L Gressier, et al.
Journal of Virology|September 12, 2000
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cellsA Samri, G Haas, J Duntze, et al.
HIV Medicine|August 30, 2008
Stability of HIV RNA in plasma specimens stored at different temperaturesB Amellal, R Murphy, A Maiga, et al.
Journal of Virology|December 1, 1994
Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in miceT Couderc, N Guédo, V Calvez, et al.
The British Journal of Dermatology|May 27, 2009
Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative studyP Saiag, A Bauhofer, F Bouscarat, et al.
Pageof 20